New England Research & Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.79M Buy
20,441
+1,335
+7% +$248K 1.8% 12
2025
Q1
$4M Sell
19,106
-2,266
-11% -$475K 2.03% 11
2024
Q4
$3.8M Buy
21,372
+8,280
+63% +$1.47M 1.93% 11
2024
Q3
$2.59M Buy
13,092
+1,616
+14% +$319K 1.21% 23
2024
Q2
$1.97M Buy
11,476
+6,408
+126% +$1.1M 0.95% 32
2024
Q1
$923K Buy
5,068
+41
+0.8% +$7.47K 0.45% 77
2023
Q4
$779K Sell
5,027
-573
-10% -$88.8K 0.41% 84
2023
Q3
$835K Sell
5,600
-333
-6% -$49.7K 0.48% 74
2023
Q2
$799K Sell
5,933
-22
-0.4% -$2.96K 0.46% 74
2023
Q1
$949K Sell
5,955
-100
-2% -$15.9K 0.56% 69
2022
Q4
$979K Sell
6,055
-3,075
-34% -$497K 0.56% 68
2022
Q3
$1.23M Buy
9,130
+3,100
+51% +$416K 0.77% 41
2022
Q2
$924K Hold
6,030
0.54% 66
2022
Q1
$978K Sell
6,030
-9,628
-61% -$1.56M 0.51% 68
2021
Q4
$2.12M Hold
15,658
1.03% 26
2021
Q3
$1.69M Sell
15,658
-75
-0.5% -$8.09K 0.88% 36
2021
Q2
$1.77M Sell
15,733
-50
-0.3% -$5.63K 0.92% 32
2021
Q1
$1.71M Buy
15,783
+63
+0.4% +$6.82K 0.94% 34
2020
Q4
$1.68M Buy
15,720
+1,100
+8% +$118K 1.04% 29
2020
Q3
$1.28M Sell
14,620
-85
-0.6% -$7.45K 0.93% 32
2020
Q2
$1.44M Buy
14,705
+4,750
+48% +$466K 1.03% 26
2020
Q1
$758K Sell
9,955
-425
-4% -$32.4K 0.65% 56
2019
Q4
$919K Sell
10,380
-1,450
-12% -$128K 0.62% 61
2019
Q3
$896K Buy
11,830
+4,750
+67% +$360K 0.65% 52
2019
Q2
$515K Sell
7,080
-1,079
-13% -$78.5K 0.35% 99
2019
Q1
$658K Buy
8,159
+300
+4% +$24.2K 0.44% 79
2018
Q4
$725K Sell
7,859
-5,674
-42% -$523K 0.57% 63
2018
Q3
$1.28M Sell
13,533
-2,650
-16% -$251K 0.83% 42
2018
Q2
$1.5M Buy
16,183
+1,850
+13% +$171K 0.99% 28
2018
Q1
$1.36M Buy
14,333
+9,800
+216% +$928K 0.91% 37
2017
Q4
$438K Sell
4,533
-4,775
-51% -$461K 0.31% 100
2017
Q3
$827K Buy
9,308
+4,700
+102% +$418K 0.61% 63
2017
Q2
$334K Hold
4,608
0.25% 121
2017
Q1
$300K Sell
4,608
-4,150
-47% -$270K 0.23% 132
2016
Q4
$548K Buy
8,758
+4,950
+130% +$310K 0.43% 76
2016
Q3
$240K Sell
3,808
-11,700
-75% -$737K 0.2% 145
2016
Q2
$960K Sell
15,508
-3,100
-17% -$192K 0.83% 38
2016
Q1
$1.06M Buy
18,608
+1,950
+12% +$111K 0.9% 34
2015
Q4
$987K Buy
16,658
+7,550
+83% +$447K 0.85% 32
2015
Q3
$496K Buy
9,108
+4,300
+89% +$234K 0.47% 77
2015
Q2
$323K Sell
4,808
-11,099
-70% -$746K 0.26% 126
2015
Q1
$931K Buy
15,907
+7,499
+89% +$439K 0.8% 40
2014
Q4
$550K Sell
8,408
-200
-2% -$13.1K 0.47% 90
2014
Q3
$497K Sell
8,608
-550
-6% -$31.8K 0.43% 97
2014
Q2
$517K Sell
9,158
-5,400
-37% -$305K 0.46% 90
2014
Q1
$748K Buy
14,558
+4,700
+48% +$241K 0.69% 59
2013
Q4
$521K Buy
+9,858
New +$521K 0.5% 80